The “Iuliu Hatieganu” University of Medicine and Pharmacy (UMF) in Cluj-Napoca, together with six other universities in Europe, is developing a master’s programme for neurotechnology specialists that will combine, among other areas, artificial intelligence and medicine.
“Romania contributes to the training of a new generation of neurotechnology specialists. The ‘Iuliu Hatieganu’ University of Medicine and Pharmacy in Cluj-Napoca is developing a master’s programme alongside six other European universities. The European Master in Neurotechnology will train specialists in areas combining medicine, artificial intelligence and technologies applied to the brain. Participants will also study brain-computer interfaces and learn how to use AI in brain research. The programme is being developed by the NeurotechEU Alliance [the European University of Brain and Technology – an alliance of nine leading European universities working together to establish a trans-European network of excellence in brain research and technology], of which the ‘Iuliu Hatieganu’ University of Medicine and Pharmacy is a founding member, alongside universities in the Netherlands, Spain, Germany, Türkiye, France and Iceland. The programme, scheduled to begin in the 2027-2028 academic year, will train specialists in a field at the intersection of medicine, neuroscience, artificial intelligence and engineering,” UMF Cluj said in a release.
According to the quoted source, the European Master in Neurotechnology (EMN) will include the study of brain-computer interfaces, devices and sensors used in neurological research, as well as artificial intelligence and neural data analysis. The master’s programme also covers the applications of neurotechnology in medicine, including the diagnosis, treatment and rehabilitation of patients with neurological disorders.
The “Iuliu Hatieganu” UMF will contribute to two components of the master’s programme, Clinical and Technology, drawing on its expertise in clinical research and the integration of modern technologies into medicine.
Through the university’s contribution to the development of this European programme, Romania is strengthening its presence in the area of neurotechnology, opening up new prospects for medical education and research.
“The ‘Iuliu Hatieganu’ University of Medicine and Pharmacy in Cluj-Napoca’s participation in the development of the European Master in Neurotechnology reflects the direction in which medicine is evolving: towards greater interdisciplinarity, international cooperation and the integration of technology. Our university’s involvement in this joint master’s programme also means taking an active role in developing new European educational models, in which universities pool their expertise, resources and capacity for innovation. This is an essential direction for training the professionals Europe will need in the coming years,” UMF Cluj Rector Anca Dana Buzoianu said, according to the release.
The European Master in Neurotechnology will last two years, will be taught in English and will give students the opportunity to study and conduct research at the partner universities. International mobility will be compulsory in the third semester, and graduates will receive a joint degree from the seven participating universities.
The programme is being developed in collaboration with academic institutions in the Netherlands, Spain, Germany, Türkiye, France and Iceland and will be open to candidates with relevant academic backgrounds, including those from outside the partner universities and outside Europe.
